vectastain elite abc reagent (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
96
Structured Review
Vector Laboratories
vectastain elite abc reagent
Vectastain Elite Abc Reagent, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 2293 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vectastain+elite+abc+reagent/VECTASTAIN+Elite+ABC+HRP+Reagent%2C+R%2ET%2EU%2E+(Peroxidase%2C+Ready-to-Use)/pm42823747-192-16-20
Average 96 stars, based on 2293 article reviews
Vectastain Elite Abc Reagent, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 2293 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vectastain+elite+abc+reagent/VECTASTAIN+Elite+ABC+HRP+Reagent%2C+R%2ET%2EU%2E+(Peroxidase%2C+Ready-to-Use)/pm42823747-192-16-20
Average 96 stars, based on 2293 article reviews
vectastain elite abc reagent - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Cross-species transcriptomics identify mineralocorticoid receptor pathway overactivation as a central driver of ocular rosacea. Article Snippet: For other primary antibodies, sections were processed with Incubation:Article Title: Functional analysis of adrenocorticotropic-hormone-producing pituitary cells derived from human pluripotent stem cells in murine and primate models of hypopituitarism. Article Snippet: The primary antibodies employed were anti-ACTH (mouse, 1:1000; MA5-13455, Thermo Fisher Scientific), anti-Ki67 (rabbit, 1:1000; MAB7617, R&D Systems), anti-CD3 (mouse, 1:500; NCL-CD3, Leica Biosystems, Deer Park, IL), anti-CD20 (mouse, 1:200; NCL-CD20, Leica Biosystems), and anti-CD68 (mouse, 1:500; M0814, Dako, Santa Clara, CA), all diluted in the blocking buffer provided in tyramide signal amplification kit 15 (Akoya Biosciences) and applied overnight at 4 °C. .. After 3 washes in PBS, the sections were incubated with diluted biotinylated secondary antibodies provided in VECTASTAIN Elite ABC reagent ( Article Title: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression Article Snippet: After washing with TBS-T, the slides were incubated with a secondary antibody VECTASTAIN biotinylated horse anti-rabbit/mouse (PK-8200, Vector Laboratories, US). .. Following additional TBS-T washes, sections were incubated in the Article Title: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression. Article Snippet: After washing with TBS-T, the slides were incubated with a secondary antibody VECTASTAIN biotinylated horse anti-rabbit/mouse (PK-8200, Vector Laboratories, US). .. Following additional TBS-T washes, sections were incubated in the Article Title: Lactiplantibacillus plantarum K4-9 strain stimulates antitumor immune responses through the activation of dendritic cells and CD8 + T cells. Article Snippet: Activated dendritic cells (DCs) present tumor antigens to T cells, while CD8 T cells induce apoptosis in cancer cells through the production of interferon (IFN)-γ and Granzyme B.. Immune cells expressing chemokine receptors migrate to tumor sites in response to chemokines secreted by cancer cells.. In our previous study, we demonstrated that Lactiplantibacillus plantarum K4–9 (K4–9), isolated from nozawana pickles, strongly promotes IFN-γ production. Article Title: Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis Article Snippet: .. After PBS washes, sections were incubated with the Staining:Article Title: PP2A activation targets MYCN in neuroblastoma Article Snippet: The slides were washed with PBS and rabbit secondary antibody (R.T.U. biotinylated universal antibody, Vector Laboratories, Burlingame, CA, USA) added for 30 minutes at 22 °C. .. Staining reaction was applied for 30 min at RT with Article Title: PMEPA1 promotes mTOR inhibitor resistance in triple-negative breast cancer: Targeting the TGF-β/PMEPA1 axis as a therapeutic strategy to overcome resistance. Article Snippet: Acquired resistance to mammalian target of rapamycin inhibitors (mTORi) severely limits their clinical efficacy in triple-negative breast cancer (TNBC), a subtype devoid of targeted therapeutic options.. To model acquired resistance, we established two mTORi-resistant TNBC cell lines, MDA-MB-231/DREVE and MDA-MB-231/DRRIDA through chronic exposure to everolimus and ridaforolimus, respectively.. These resistant cells exhibited sustained mTOR signaling, evasion of G1 arrest, enhanced migratory potential, and anchorage-independent growth. |